Optometrists are lobbying for more leeway to treat patients — and physicians' groups are pushing back. But it's more than a turf war, both sides say, as they explain why patients' vision is at stake.
Up to 16 million people in the U.S. have undiagnosed or uncorrected vision errors that could be helped by glasses, contact lenses or surgery. But many health plans don't include routine vision care.
Senators cited ProPublica reporting that found drug companies have been making patients pay for oversize eyedrops and more liquid cancer medications than they need.
When eyedrops dribble down your face, it's not your fault. Drugmakers have long known that their drops of medicine exceed the capacity of the human eye. Why didn't companies make the drops smaller?
The U.S. Preventive Services Task Force says there isn't enough evidence to know whether vision screening given by primary care doctors benefits patients.